Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 83, Issue 3, Pages 1011-1016Publisher
IOS PRESS
DOI: 10.3233/JAD-210420
Keywords
Alzheimer's disease; de novo mutation; early-onset dementia; presenilin 1 mutation; posterior cortical atrophy
Categories
Funding
- Instituto de Investigaci 'on Carlos III [PI20/00469]
- FEDER funds, Spain
Ask authors/readers for more resources
We report a patient with sporadic Alzheimer's disease onset in his twenties carrying a de novo Pro436Gln mutation in the PS1 gene. The clinical phenotype includes posterior cortical syndrome and mild limb spasticity, with brain imaging showing severe parieto-occipital atrophy. Cerebrospinal fluid biomarkers indicate worsening condition.
We report a patient with sporadic Alzheimer's disease with onset in his twenties found to carry the de novo Pro436Gln mutation in the presenilin 1 gene (PS1). Clinical phenotype featured a posterior cortical syndrome with severe visual agnosia and mild limb spasticity with brisk reflexes. Brain MRI and FDG-PET scans revealed severe parieto-occipital atrophy/hypometabolism. Cerebrospinal fluid biomarkers showed a decrease in A beta(42) level and A beta(42/40) ratio, increased phospho-tau, and normal total tau. Amyloid PET identified a very high burden of amyloid-beta neuritic plaques in the posterior cortex Similarities between this and two previously reported cases with this variant support that this mutation has a very strong impact on the clinical phenotype and is consistently associated with spasticity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available